相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Identification of Bruton's tyrosine kinase as a therapeutic target in acute myeloid leukemia
Stuart A. Rushworth et al.
BLOOD (2014)
BRAF Inhibitor Resistance Mechanisms in Metastatic Melanoma: Spectrum and Clinical Impact
Helen Rizos et al.
CLINICAL CANCER RESEARCH (2014)
Ibrutinib as initial therapy for elderly patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: an open-label, multicentre, phase 1b/2 trial
Susan O'Brien et al.
LANCET ONCOLOGY (2014)
Obinutuzumab plus Chlorambucil in Patients with CLL and Coexisting Conditions
Valentin Goede et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Targeting B-cell anergy in chronic lymphocytic leukemia
Benedetta Apollonio et al.
BLOOD (2013)
Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes
Jason A. Dubovsky et al.
BLOOD (2013)
Precision medicines for B-cell leukaemias and lymphomas; progress and potential pitfalls
Martin J. S. Dyer et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Single-agent lenalidomide is active in patients with relapsed or refractory aggressive non-Hodgkin lymphoma who received prior stem cell transplantation
Julie M. Vose et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Targeting BCL-2 with the BH3 Mimetic ABT-199 in Estrogen Receptor-Positive Breast Cancer
Francois Vaillant et al.
CANCER CELL (2013)
A novel isoform of the B cell tyrosine kinase BTK protects breast cancer cells from apoptosis
Cheryl Eifert et al.
GENES CHROMOSOMES & CANCER (2013)
Bruton's Tyrosine Kinase mediates platelet receptor-induced generation of microparticles: A potential mechanism for amplification of inflammatory responses in rheumatoid arthritis synovial joints
Jonathan Hsu et al.
IMMUNOLOGY LETTERS (2013)
Cancer Drugs in the United States: Justum Pretium-The Just Price
Hagop M. Kantarjian et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Bruton's Tyrosine Kinase Is Required for Apoptotic Cell Uptake via Regulating the Phosphorylation and Localization of Calreticulin
Jennifer C. Byrne et al.
JOURNAL OF IMMUNOLOGY (2013)
CANCER'S TRUE BREAKTHROUGHS
Elie Dolgin
NATURE MEDICINE (2013)
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
Andrew J. Souers et al.
NATURE MEDICINE (2013)
Irreversible kinase inhibitors gain traction
Katharine Sanderson
NATURE REVIEWS DRUG DISCOVERY (2013)
Targeting pathological B cell receptor signalling in lymphoid malignancies
Ryan M. Young et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
James E. Neffendorf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
John C. Byrd et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Inhibitors of BTK and ITK: State of the New Drugs for Cancer, Autoimmunity and Inflammatory Diseases
L. Vargas et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2013)
B cell receptor signaling in chronic lymphocytic leukemia
Jan A. Burger et al.
TRENDS IN IMMUNOLOGY (2013)
GS-1101: A Delta-Specific PI3K Inhibitor in Chronic Lymphocytic Leukemia
Ines M. Macias-Perez et al.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2013)
X-ray crystallographic structure-based design of selective thienopyrazole inhibitors for interleukin-2-inducible tyrosine kinase
Larry R. McLean et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Exploiting Synthetic Lethality for the Therapy of ABC Diffuse Large B Cell Lymphoma
Yibin Yang et al.
CANCER CELL (2012)
Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling
Marcus Duehren-von Minden et al.
NATURE (2012)
The kinase Btk negatively regulates the production of reactive oxygen species and stimulation-induced apoptosis in human neutrophils
Fumiko Honda et al.
NATURE IMMUNOLOGY (2012)
Significant Species Difference in Amide Hydrolysis of GDC-0834, a Novel Potent and Selective Bruton's Tyrosine Kinase Inhibitor
Lichuan Liu et al.
DRUG METABOLISM AND DISPOSITION (2011)
Tec family kinases
Liang Yu et al.
FEBS JOURNAL (2011)
IL-2-inducible T-cell kinase deficiency: clinical presentation and therapeutic approach
Polina Stepensky et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Specific Btk inhibition suppresses B cell- and myeloid cell-mediated arthritis
Julie A. Di Paolo et al.
NATURE CHEMICAL BIOLOGY (2011)
Insights into the conformational flexibility of Bruton's tyrosine kinase from multiple ligand complex structures
Andreas Kuglstatter et al.
PROTEIN SCIENCE (2011)
The fusion kinase ITK-SYK mimics a T cell receptor signal and drives oncogenesis in conditional mouse models of peripheral T cell lymphoma
Konstanze Pechloff et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
R. Eric Davis et al.
NATURE (2010)
The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy
Lee A. Honigberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
PI3 Kinase Signals BCR-Dependent Mature B Cell Survival
Lakshmi Srinivasan et al.
CELL (2009)
Girls homozygous for an IL-2-inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation
Kirsten Huck et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Discovery of selective irreversible inhibitors for Bruton's tyrosine kinase
Zhengying Pan et al.
CHEMMEDCHEM (2007)
Bruton's tyrosine kinase and phospholipase C gamma 2 mediate chemokine-controlled B cell migration and homing
David J. J. de Gorter et al.
IMMUNITY (2007)
BDTKbase:: The mutation database for X-linked agammaglobullinemia
Jouni Valiaho et al.
HUMAN MUTATION (2006)
Roles for phosphoinositide 3-kinases, Bruton's tyrosine kinase, and Jun kinases in B lymphocyte chemotaxis and homing
Saida Ortolano et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma
B Streubel et al.
LEUKEMIA (2006)
Survival of resting mature B lymphocytes depends on BCR signaling via the Igα/β heterodimer
M Kraus et al.
CELL (2004)
G protein βγ subunits act on the catalytic domain to stimulate Bruton's agammaglobulinemia tyrosine kinase
WE Lowry et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Crystal structure of Bruton's tyrosine kinase domain suggests a novel pathway for activation and provides insights into the molecular basis of X-linked agammaglobulinemia
C Mao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Signaling network of the Btk family kinases
Y Qiu et al.
ONCOGENE (2000)
分享论文
